Literature DB >> 40288

The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools.

S E Robinson, S Berney, R Mishra, F Sulser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 40288     DOI： 10.1007/bf00496054

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  46 in total

1.  Structural and steric requirements for beta-phenethylamines as agonists of the noradrenergic cyclic AMP generating system in the rat limbic forebrain.

Authors:  S E Robinson; P L Mobley; H E Smith; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

2.  Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain.

Authors:  S J Peroutka; D C U'Prichard; D A Greenberg; S H Snyder
Journal:  Neuropharmacology       Date:  1977-09       Impact factor: 5.250

3.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Science       Date:  1976-04-30       Impact factor: 47.728

4.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

5.  [Clinical and electroencephalographic effects of methoclopramide in psychiatry].

Authors:  P Borenstein; G Bles
Journal:  Therapie       Date:  1965 Jul-Aug       Impact factor: 2.070

6.  Effect of metoclopramide-induced prolactin on aldosterone secretion in normal subjects.

Authors:  T Ogihara; S Matsumura; T Onishi; K Miyai; T Uozumi
Journal:  Life Sci       Date:  1977-02-01       Impact factor: 5.037

7.  Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosine.

Authors:  H A Nasrallah; E F Donnelly; L B Bigelow; L Rivera-Calimlim; A Rogol; S Potkin; F P Rauscher; R J Wyatt
Journal:  Arch Gen Psychiatry       Date:  1977-06

8.  Schizophrenic symptoms improve with apomorphine.

Authors:  C A Tamminga; M H Schaffer; R C Smith; J M Davis
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

9.  Norepinephrine in chronic paranoid schizophrenia: above-normal levels in limbic forebrain.

Authors:  I J Farley; K S Price; E McCullough; J H Deck; W Hordynski; O Hornykiewicz
Journal:  Science       Date:  1978-04-28       Impact factor: 47.728

10.  A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue.

Authors:  D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1963-02
View more
  10 in total

1.  Down-regulation of tryptamine binding sites following chronic molindone administration. A comparison with responses of dopamine and 5-hydroxytryptamine receptors.

Authors:  T V Nguyen; A V Juorio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

2.  Relationship between plasma concentration and arousal in normal subjects after single oral and parenteral doses of melperone, a butyrophenone neuroleptic.

Authors:  L Molander; L Borgström
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

3.  Typical and atypical neuroleptics are potent antagonists at alpha 1-adrenoceptors of the dorsal lateral geniculate nucleus. An electrophysiological study.

Authors:  J Marwaha; G K Aghajanian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

Review 4.  Assessment of anti-psychotic drugs.

Authors:  A V Mackay
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

5.  Interactions of a neuroleptic drug (fluphenazine) with catecholamines in hippocampus.

Authors:  M R Palmer; R Freedman; T V Dunwiddie
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Amphetamine stereotypies and polyribosomal disaggregation in rats: effects of adrenergic and serotonergic blocking agents.

Authors:  M M Widelitz; C P Hable
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

7.  Electrophysiologic interactions of antipsychotic drugs with central noradrenergic pathways.

Authors:  J Marwaha; B J Hoffer; H M Geller; R Freedman
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor models.

Authors:  M Stanley; A Lautin; J Rotrosen; S Gershon; D Kleinberg
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

9.  Effects of clozapine in a selective muscarinic bioassay and on single cells of the rat hippocampus.

Authors:  P L Herrling; B Misbach-Lesenne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000

10.  Mimicking of Phase I Metabolism Reactions of Molindone by HLM and Photocatalytic Methods with the Use of UHPLC-MS/MS.

Authors:  Maciej Gawlik; Vladimir Savic; Milos Jovanovic; Robert Skibiński
Journal:  Molecules       Date:  2020-03-17       Impact factor: 4.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.